Hainan Shuangcheng Pharmaceuticals announced that the company plans to purchase 100% equity of Ningbo Aura Semiconductor Co., Ltd. held by 25 trading partners through issuance of shares and cash payment, and intends to issue shares to raise matching funds from up to 35 specific investors. This transaction is expected to constitute a related-party transaction, a significant asset restructuring, but not a restructuring for listing. As of the announcement date, the company and relevant parties are actively promoting various work related to this transaction. Currently, due diligence, audits, evaluations, and other works related to this transaction are in progress. However, this transaction still requires re-evaluation by the company's board of directors and approval by the company's shareholders' meeting, and formal implementation can only proceed after approval by the relevant regulatory authorities, with some uncertainties regarding approval.